Jeffrey A. Wolfson
New York
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Jeffrey A. Wolfson
Hasty Provisional Costs Millions in Lost Revenue: Lessons from Enanta v. Pfizer
We've updated our Privacy Statement. Before you continue, please read our new Privacy Statement and familiarize yourself with the terms.
Hasty Provisional Costs Millions in Lost Revenue: Lessons from Enanta v. Pfizer
We've updated our Privacy Statement. Before you continue, please read our new Privacy Statement and familiarize yourself with the terms.
Tune In: Understanding Google v. Sonos and its Patent Prosecution Implications
“Post-Google, practitioners may mitigate risk of a prosecution laches challenge for a later continuation if their first-filed publication signals a likelihood of pursuing additional claims of different scope in the future.” The U.S. Court of Appeals for the Federal Circuit issued its long-awaited decision in Google LLC v. Sonos, Inc. on August 28, 2025, providing guidance on the doctrine of prosecution laches.
NIH Issues Guidance Capping Grant Indirect Cost Rates at 15%, Drawing Multiple Legal Challenges Affecting Research-Based Organizations and R&D Innovation
The National Institutes of Health (NIH) issued NIH Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates, Notice Number NOT-OD-25-068 (Feb. 7, 2025) (NIH Guidance or Guidance), which establishes a standard indirect cost rate (also known as a Facilities and Administration or F&A rate) of 15% across all NIH grants, regardless of existing negotiated indirect cost rates.
Standing in the shifted landscape: patent enablement following 'Amgen v. Sanofi'
(August 05, 2024) - Jeffrey D. Morton and Jeffrey Wolfson of Haynes and Boone LLP explore the implications of the 2023 U.S. Supreme Court decision in Amgen v. Sanofi, noting the USPTO patent examiner guidance and shifting approaches to patent drafting. A little over one year ago, in May 2023, the United States Supreme Court issued the unanimous decision on patent enablement in Amgen v. Sanofi (hereinafter referred to as the "Amgen" decision).
The IP Beacon September 2023
David A. Bell Partner | Co-Chair - Trademark and Advertising Practice Group Dallas T +1 214.651.5248 Email Dina Blikshteyn Partner New York T +1 212.835.4809 Email Jason P. Bloom Partner | Chair - Intellectual Property Litigation | Chair - Copyright Practice Group Dallas T +1 214.651.5655 Email Russ Emerson Partner Dallas T +1 214.651.5328 Email Tiffany Ferris Partner | Co-Chair – Trademark and Advertising Practice Group Dallas T +1 214.651.5152 Email Gavin D.
Mirror, Mirror? A New PDF Backup Option For DOCX Filings Via Patent Center
In an effort to ease the transition to the new DOCX filing format for non-provisional utility patent applications, the United States Patent and Trademark Office (USPTO) recently announced it will allow the option to file an applicant-generated PDF along with the DOCX filing of the application through December 31, 2022.
The IP Beacon, November 2020
United States: The IP Beacon, November 2020 10 December 2020 by Joseph R. Mencher and Jeffrey A. Wolfson Haynes and Boone To print this article, all you need is to be registered or login on Mondaq.com. David Bell and Mike McArthur in Intellectual Property Magazine: Name Drop It's official: the Washington Redskins are no more. Well, the name, that is. Despite team owner Daniel Snyder's famous 2013 proclamation – "We'll never change the name. It's that simple. NEVER.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Jeffrey A.
Contact Jeffrey A., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack